desipramine has been researched along with Prostatic Neoplasms in 4 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HC | 1 |
| Huang, CC | 1 |
| Huang, CJ | 2 |
| Cheng, JS | 1 |
| Liu, SI | 2 |
| Tsai, JY | 1 |
| Chang, HT | 1 |
| Huang, JK | 1 |
| Chou, CT | 2 |
| Jan, CR | 2 |
| Ma, G | 1 |
| Troxel, AB | 1 |
| Heitjan, DF | 1 |
| Liu, X | 1 |
| Zeidan, YH | 1 |
| Elojeimy, S | 1 |
| Holman, DH | 1 |
| El-Zawahry, AM | 1 |
| Guo, GW | 1 |
| Bielawska, A | 1 |
| Bielawski, J | 1 |
| Szulc, Z | 1 |
| Rubinchik, S | 1 |
| Dong, JY | 1 |
| Keane, TE | 1 |
| Tavassoli, M | 1 |
| Hannun, YA | 1 |
| Norris, JS | 1 |
| Cheng, HH | 1 |
| Kuo, CC | 1 |
| Lu, YC | 1 |
| Tseng, LL | 1 |
| Chu, ST | 1 |
| Hsu, SS | 1 |
| Wang, JL | 1 |
| Lin, KL | 1 |
| Chen, IS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies[NCT01515124] | 450 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| [NCT00037362] | 0 participants | Observational | 2001-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for desipramine and Prostatic Neoplasms
| Article | Year |
|---|---|
Desipramine-induced apoptosis in human PC3 prostate cancer cells: activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2+]i elevation.
Topics: Antidepressive Agents, Tricyclic; Apoptosis; Calcium; Caspase 3; Cell Line, Tumor; Cell Survival; Cy | 2008 |
An index of local sensitivity to nonignorable drop-out in longitudinal modelling.
Topics: Animal Feed; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Hormonal; Cattle; Coc | 2005 |
An index of local sensitivity to nonignorable drop-out in longitudinal modelling.
Topics: Animal Feed; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Hormonal; Cattle; Coc | 2005 |
An index of local sensitivity to nonignorable drop-out in longitudinal modelling.
Topics: Animal Feed; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Hormonal; Cattle; Coc | 2005 |
An index of local sensitivity to nonignorable drop-out in longitudinal modelling.
Topics: Animal Feed; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Hormonal; Cattle; Coc | 2005 |
Involvement of sphingolipids in apoptin-induced cell killing.
Topics: Adenoviridae; Apoptosis; Capsid Proteins; Cell Line, Tumor; Cell Membrane; Ceramides; Desipramine; D | 2006 |
Desipramine-induced Ca2+ movement and cytotoxicity in PC3 human prostate cancer cells.
Topics: Antidepressive Agents; Calcium; Calcium Signaling; Cell Survival; Chelating Agents; Desipramine; Dos | 2007 |